0001520138-23-000109.txt : 20230222 0001520138-23-000109.hdr.sgml : 20230222 20230222174739 ACCESSION NUMBER: 0001520138-23-000109 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230216 FILED AS OF DATE: 20230222 DATE AS OF CHANGE: 20230222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MARKHAM PENELOPE CENTRAL INDEX KEY: 0001770555 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39015 FILM NUMBER: 23654889 MAIL ADDRESS: STREET 1: C/O BIOVIE, INC STREET 2: 2120 COLORADO AVENUE, SUITE 230 CITY: SANTA MONICA STATE: CA ZIP: 90404 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOVIE INC. CENTRAL INDEX KEY: 0001580149 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462510769 STATE OF INCORPORATION: NV FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 680 W NYE LANE STREET 2: SUITE 201 CITY: CARSON CITY STATE: NV ZIP: 89703 BUSINESS PHONE: 775-888-3162 MAIL ADDRESS: STREET 1: 680 W NYE LANE STREET 2: SUITE 201 CITY: CARSON CITY STATE: NV ZIP: 89703 FORMER COMPANY: FORMER CONFORMED NAME: NANOANTIBIOTICS, INC. DATE OF NAME CHANGE: 20130625 4 1 ownership.xml X0306 4 2023-02-16 0 0001580149 BIOVIE INC. BIVI 0001770555 MARKHAM PENELOPE C/O BIOVIE INC. 680 W NYE LANE STE 201 CARSON CITY NV 89703 0 1 0 0 EVP Liver Cirrhosis R&D COMMON STOCK 2023-02-16 4 F 0 2476 6.12 D 47841 D Transaction code F - Payment of tax liability by withholding securities incident to the receipt /S/ PENELOPE MARKHAM 2023-02-22